HOOKIPA Pharma Inc. (HOOK)
NASDAQ: HOOK · Real-Time Price · USD
2.300
-0.420 (-15.44%)
Nov 21, 2024, 4:00 PM EST - Market closed
HOOKIPA Pharma Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2017 |
| Revenue | 50 | 20.13 | 14.25 | 18.45 | 19.58 | 11.94 | Upgrade
|
| Revenue Growth (YoY) | 143.30% | 41.27% | -22.76% | -5.80% | 63.99% | 56.53% | Upgrade
|
| Cost of Revenue | 59.9 | 85.08 | 67.22 | 80.94 | 53.13 | 46.31 | Upgrade
|
| Gross Profit | -9.91 | -64.95 | -52.97 | -62.5 | -33.55 | -34.37 | Upgrade
|
| Selling, General & Admin | 20.45 | 19.98 | 20.19 | 19.18 | 19.74 | 16.72 | Upgrade
|
| Operating Expenses | 35.85 | 19.98 | 20.19 | 19.18 | 19.74 | 16.72 | Upgrade
|
| Operating Income | -45.75 | -84.93 | -73.16 | -81.67 | -53.29 | -51.09 | Upgrade
|
| Interest Expense | -0.05 | -0.32 | -0.69 | -0.9 | -0.79 | -0.88 | Upgrade
|
| Interest & Investment Income | 4.45 | 5.29 | 1.63 | 0.03 | 0.4 | 1.59 | Upgrade
|
| Other Non Operating Income (Expenses) | 13.28 | 11.51 | 7.52 | 6.88 | 9.59 | 7.34 | Upgrade
|
| EBT Excluding Unusual Items | -28.07 | -68.45 | -64.69 | -75.66 | -44.08 | -43.04 | Upgrade
|
| Asset Writedown | -12.94 | -12.77 | - | - | - | - | Upgrade
|
| Pretax Income | -43.21 | -81.21 | -64.69 | -75.66 | -44.08 | -43.04 | Upgrade
|
| Income Tax Expense | 0.16 | 0.37 | 0.23 | 0 | - | - | Upgrade
|
| Net Income | -43.37 | -81.58 | -64.92 | -75.67 | -44.08 | -43.04 | Upgrade
|
| Net Income to Common | -43.37 | -81.58 | -64.92 | -75.67 | -44.08 | -43.04 | Upgrade
|
| Shares Outstanding (Basic) | 12 | 9 | 7 | 3 | 3 | 2 | Upgrade
|
| Shares Outstanding (Diluted) | 12 | 9 | 7 | 3 | 3 | 2 | Upgrade
|
| Shares Change (YoY) | 44.77% | 44.29% | 99.53% | 26.09% | 45.80% | 1853.23% | Upgrade
|
| EPS (Basic) | -3.55 | -8.63 | -9.91 | -23.04 | -16.93 | -24.10 | Upgrade
|
| EPS (Diluted) | -3.55 | -8.63 | -9.91 | -23.04 | -16.93 | -24.10 | Upgrade
|
| Free Cash Flow | -67.88 | -61.68 | -25.01 | -78.6 | -41.71 | -43.73 | Upgrade
|
| Free Cash Flow Per Share | -5.55 | -6.53 | -3.82 | -23.94 | -16.02 | -24.48 | Upgrade
|
| Gross Margin | -19.81% | - | - | - | -171.31% | -287.81% | Upgrade
|
| Operating Margin | -91.51% | -421.92% | -513.40% | -442.73% | -272.08% | -427.78% | Upgrade
|
| Profit Margin | -86.74% | -405.29% | -455.58% | -410.15% | -225.09% | -360.38% | Upgrade
|
| Free Cash Flow Margin | -135.76% | -306.44% | -175.55% | -426.05% | -212.98% | -366.19% | Upgrade
|
| EBITDA | -42.42 | -81.38 | -69.55 | -77.03 | -49.14 | -48.02 | Upgrade
|
| EBITDA Margin | -84.84% | - | - | - | -250.89% | - | Upgrade
|
| D&A For EBITDA | 3.33 | 3.55 | 3.6 | 4.64 | 4.15 | 3.07 | Upgrade
|
| EBIT | -45.75 | -84.93 | -73.16 | -81.67 | -53.29 | -51.09 | Upgrade
|
| EBIT Margin | -91.51% | - | - | - | -272.08% | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.